Citius Oncology, Inc. (CTOR) vs Lifecore Biomedical, Inc. (LFCR)
Citius Oncology, Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Lifecore Biomedical, Inc. is the larger, with a market value of $162.4M against $97.6M — 1.7× the size. Citius Oncology, Inc. has the higher net margin (0.00% vs −37.5%) and the lower return on invested capital (−67.2% vs −2.80%). Across the 12 metrics below, Lifecore Biomedical, Inc. leads on 7 and Citius Oncology, Inc. on 5.
Valuation
Profitability
| Metric | CTOR | LFCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | — | 26.86% | 53.94% |
| Operating margin | 0.00% | (6.89%) | 0.00% |
| Net margin | 0.00% | (37.54%) | 0.00% |
| Free cash flow margin | 0.00% | (4.24%) | 0.00% |
| Return on equity | (126.58%) | 201.15% | (0.40%) |
| Return on assets | (45.20%) | (19.32%) | (3.32%) |
| Return on invested capital | (67.15%) | (2.80%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack